
Co-Editors-In-Chief:
Atta-ur-Rahman, FRS
International Centre for Chemical and Biological Sciences
University of Karachi
Karachi
Pakistan
M. Iqbal Choudhary
H.E.J. Research Institute of Chemistry
University of Karachi
Karachi
Pakistan
George Perry
College of Sciences
The University of Texas at San Antonio
Texas
USA
Regional Editors:
D. Barlocco (Universita di
Milano, Milano, Italy)
M. Bernard (University of Namur, Namur, Belgium)
G. Bertho (Université René
Descartes Paris, Paris, France)
P. Chiba (Universität Wien, Vienna,
Austria)
P. Conti (Istituto di Chimica Farmaceutica
Milano, Italy)
M.P. Costi (Universitá degli Studi
di Modena, Modena, Italy)
A. Gueiffier (Universite Tours, Tours, France)
S.M. Husbands (University of Bath, Bath,
UK)
R.J. Hwu (Tsing Hua University, Hsinchu,
Taiwan)
H. Kalasz (Semmelweis University, Budapest,
Hungary)
Y. Kawakami (Eisai Co., Ltd., Ibaraki, Japan)
M.L. Lopez-Rodriguez (University of Madrid,
Madrid, Spain)
A. Martinez (Instituto de Quimica Medica-CSIC,
Madrid, Spain)
C. Meier (Universitaet Hamburg, Hamburg,
Germany)
R. Muthyala (University of Minnesota, Minneapolis,
MN, USA)
F. Ooms (Euroscreen S.A., Gosselies, Belgium)
S. Sarel (The Hebrew University of Jerusalem,
Jerusalem, Israel)
K.R. Scott (Howard University, Washington,
DC, USA)
H. Shinkai (Osaka Institute of Technology,
Osaka, Japan)
M. Suzuki (Riken Kobe Institute, Kobe, Japan)
N. Tagmatarchis (Theoretical and Physical
Chemistry Institute, Athens, Greece)
R. Mcgeary (The University of Queensland,
Brisbane, Australia)
B. Zacharie (Prometic Biosciences Inc, Laval,
Canada)
Editorial Advisory Board:
A. Abell (The University of
Adelaide, Adelaide, Australia)
S. M. Ali (ArQule Inc., Woburn, MA, USA)
T.H. Altel (College of Pharmacy, UOS, UAE)
K.H. Altmann (Novartis Pharma AG, Basel,
Switzerland)
R. Bose (Ohio University, Athens, OH, USA)
H. Cerecetto (Dep. Quimica Organica, Montevideo,
Uruguay)
E. de Clerq (Katholieke Universiteit Leuven,
Leuven, Belgium)
A.K. Debnath (Lindsley F. Kimball Research
Institute, NY, USA)
A.T. Dinkova-Kostova (Johns Hopkins University,
MD, USA)
J.-M. Dogné (University of Liége,
Liége, Belgium)
Y. Dong (University of Nebraska Medical Center,
Omaha, NE, USA)
T. Girbes (Universidad de Valladolid, Vallodolid,
Spain)
S. Goldstein (Institut de Recherches Servier,
Suresnes, France)
M.M. Harding (University of Sydney, Sydney,
Australia)
A. Hilgeroth (Martin-Luther-University, Halle,
Germany)
T. Hou (Soochow University, Suzhou, Jiangsu,
China)
T.C. Jenkins (University of Bradford, Bradford,
UK)
M. Jung (Yonsei University, Seoul, Korea)
J.-F. Liegeois (University of Liege, Liege,
Belgium)
I.A. McDonald (Pharmaxis Ltd., Frenchs Forest,
Australia)
S. Mehta (Ambit Biosciences, San Diego CA,
USA)
M. Missbach (Novartis Pharma AG, Basel, Switzerland)
G.A. Morales (Semafore Pharmaceuticals Inc.,
Indianapolis, IN, USA)
P. Moreira (University of Coimbra, Coimbra,
Portugal)
C.E. Mueller (Universitaet Bonn, Bonn, Germany)
S. Nagpal (Eli Lilly and Company, Indianapolis,
IN, USA)
I. Niculescu-Duvaz (Centre for Cancer Therapeutics,
Surrey, UK)
Hideaki Natsugari (Teikyo University, Kanagawa,
Japan)
G. Petroianu (der Universitaet Heidelberg,
Mannheim, Germany)
K.W. Pankiewicz (Pharmasset, Inc., Tucker,
GA, USA)
P. Perlmutter (Monash University, Victoria,
Australia)
R.J. Quinn (AstraZeneca Nathan, Australia)
P. H. Reddy (Oregon Health and Science University,
Beaverton, USA)
P.H. Reggio (Kennesaw State University, Kennesaw,
GA, USA)
J.B. Rodriguez (Universidad de Buenos Aires,
Buenos Aires, Argentina)
D.P. Rotella (Lexicon Pharmaceuticals, Princeton,
NJ, USA)
B. Roufogalis (University of Sydney, Sydney,
Australia)
W. Sanderson (Johnson & Johnson Pharmaceutical
R& D, Beerse, Belgium)
P. M. Sexton (The University of Melbourne,
Melbourne, Australia)
Y. Song (Pfizer Global Research & Development,
MI, USA)
S. Toba (Signature Bioscience, San Francisco,
CA, USA)
I. Toth (The University of Queensland, Queensland,
Australia)
D. J. Triggle (University at Buffalo, Buffalo,
NY, USA)
B.K. Trivedi (Pfizer Global Research &
Development, MI, USA)
|